Dr. Alexander Dobranowski reports

HEALWELL'S KHURE HEALTH PROVIDES UPDATE HIGHLIGHTING SIGNIFICANT ACCELERATION IN USER AND LIFE SCIENCES PARTNER ADOPTION OF DISEASE DETECTION AI POWERED CO-PILOTS AND STRONG PHYSICIAN NPS SCORES

Healwell AI Inc. has provided a corporate update highlighting its subsidiary, Khure Health Inc., experiencing significant acceleration in user and life sciences partner adoption of its disease detection expert system AI-powered (artificial intelligence) co-pilots. In Q4 2024, Khure's co-pilots helped physicians identify over 43,000 high-risk patients across eight clinical specialities, harnessing 132 disease-specific algorithms. This figure reflected a quarter-over-quarter sequential growth of 22 per cent as compared with Q3 2024 and year-over-year growth of 500 per cent as compared with Q4 2023. Also, during Q4 2024, Healwell executed four new master services agreements (MSAs) with new large pharmaceutical partners relating to the Khure program, bringing the total number of MSAs with life sciences partners to 16, which includes seven of the 10 largest pharmaceutical companies in the world.

Highlights:

• In Q4 2024, Healwell's subsidiary, Khure Health, helped physicians identify over 43,000 high-risk patients with its AI-powered physician co-pilots, across eight clinical specialities harnessing 132 disease-specific algorithms. This figure reflected a quarter-over-quarter sequential growth of 22 per cent as compared with Q3 2024 and year-over-year growth of 500 per cent as compared with Q4 2023.
• Healwell has executed four new MSAs with new pharmaceutical partners in Q4 2024 relating to the Khure program, bringing the total number of MSAs with life sciences partners to 16, which includes seven of the 10 largest pharmaceutical companies in the world.
• Healwell recently conducted a survey of the physicians that leverage the Khure powered co-pilots that resulted in an industry-outperforming net promoter score (NPS) of 84, with 82 per cent of physicians confirming that they believed that the AI-powered physician co-pilot technology helped improve patient care.
• Healwell has now onboarded over 800 physicians that use its expert system AI-powered Khure physician co-pilots. These results include physicians that participated as part of Well Health Technologies Corp.'s network through the WAIDS (Well AI decision support) program, which is currently the fastest-growing component of the Healwell-Khure network.

Dr. Alexander Dobranowski, chief executive officer of Healwell, commented: "We are incredibly proud of the momentum our co-pilots are experiencing. In Q4 alone, our Khure technology identified 43,000 high-risk patients. This made it easier for physicians to not only identify at-risk patients but also confidently triage next steps efficiently. We now have 800 physicians using this technology and experienced 500-per-cent YoY growth and 22-per-cent QoQ growth in the number of patients identified alone. Our partnership with Well Health is working extremely well as a substantial component of our growth is now coming from the Well Health network, which includes Well clinics as well as the Wellstar provider network.

"We're also pleased to report that Khure has shown significant growth in terms of its commercialization efforts with pharma and life sciences companies as we've expanded our partnerships and signed new master services agreements that further integrate our disease-detection algorithms into critical research and patient care workflows. At Healwell, we remain committed to harnessing the power of AI to drive earlier disease detection and improve patient outcomes."

Additionally, Healwell's Khure recently conducted a survey of its physician users that resulted in an industry-outperforming net promoter score of 84, with 82 per cent of physicians confirming that they believed that the co-pilot technology helped improve patient care, thus highlighting the quality, clinical relevance and usability of Khure's clinical decision support (CDS) platform.

Healwell has now onboarded over 800 physicians that use its Khure co-pilots. The results above include physicians that participated as part of the Well Health Technologies clinical network, which includes the expanded Wellstar Technologies Corp. provider network, which offers the technology under the WAIDS program, which is currently the fastest-growing component of Khure's business. Physicians using WAIDS represented approximately 80 per cent of physicians that were onboarded into Khure in Q4.

Don Watts, president of Khure Health, further added: "Physicians using our AI decision support platform consistently report high satisfaction, as reflected in our industry-leading net promoter scores (NPS). They tell us that our platform is easy to use, saves them valuable time and, most importantly, is helping them to improve patient care. By enabling physicians with advanced technology and supporting enhanced clinical decision making, we're helping providers focus on what matters most -- delivering the best possible outcomes for their patients."

About Healwell AI Inc.

Healwell is a health care artificial intelligence company focused preventive care. Its mission is to improve health care and save lives through early identification and detection of disease. Using its own proprietary technology, the company is developing and commercializing advanced clinical decision support systems that can help health care providers detect rare and chronic diseases, improve efficiency of their practices, and ultimately help improve patient health outcomes. Healwell is executing a strategy centred around developing and acquiring technology and clinical sciences capabilities that complement the company's road map. Healwell is publicly traded on the Toronto Stock Exchange under the symbol AIDX and on the OTC (over-the-counter) exchange under the symbol HWAIF.

We seek Safe Harbor.